$MASI
MASIMO CORP Stock $masi

$masi Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000093755615000024 Filed on February 17, 2015

Income Statement

Concept	2015 Q1	2015	2013 Q4
Revenue	$161.8M	$586.6M	$142.4M
YoY Change	15.73%	0.01%	7.77%
Cost Of Revenue	$52.60M	$195.9M	$51.90M
YoY Change	10.71%	-0.02%	15.33%
Gross Profit	$109.2M	$390.8M	$90.54M
YoY Change	18.31%	-0.01%	3.85%
Gross Profit Margin	67.49%	66.61%	63.56%
Selling, General & Admin	$61.50M	$241.0M	$55.90M
YoY Change	9.58%	0.01%	8.33%
% of Gross Profit	56.32%	61.68%	61.74%
Research & Development	$15.00M	$56.58M	$13.90M
YoY Change	7.17%	-0.03%	4.51%
% of Gross Profit	13.74%	14.48%	15.35%
Depreciation & Amortization	$3.300M	$12.82M	$2.900M
YoY Change	8.45%	0.14%	0.0%
% of Gross Profit	3.02%	3.28%	3.2%
Operating Expenses	$76.50M	$287.3M	$69.90M
YoY Change	23.17%	-3.44%	7.7%
Operating Profit	$32.70M	$103.5M	$12.65M
YoY Change	8.3%	10.95%	-43.19%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.400M	-$1.472M	-$800.0K
YoY Change	-800.0%	-1.87%	-38.46%
Pretax Income	$31.20M	$69.28M	$11.90M
YoY Change	2.66%	-32.08%	-43.33%
Income Tax	$9.400M	$27.68M	$2.700M
% Of Pretax Income	30.13%	39.95%	22.69%
Net Earnings	$21.20M	$72.52M	$9.313M
YoY Change	-99.91%	0.02%	-37.94%
Net Earnings / Revenue	13.1%	12.36%	6.54%
Basic Earnings Per Share		$1.33	$0.16
Diluted Earnings Per Share	$399.2K	$1.30	$0.16
COMMON SHARES
Basic Shares Outstanding	52.61M shares	54.71M shares
Diluted Shares Outstanding		55.57M shares

Balance Sheet

Concept	2015 Q1	2015	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$134.5M	$132.3M	$95.50M
YoY Change	14.47%	-1.64%	33.38%
Cash & Equivalents	$134.5M	$132.3M	$95.47M
Short-Term Investments
Other Short-Term Assets	$21.47M	$16.30M	$19.38M
YoY Change	438.66%	13.99%	397.54%
Inventory	$69.72M	$62.00M	$56.81M
Prepaid Expenses	$9.816M		$9.243M
Receivables	$71.02M	$81.00M	$76.76M
Other Receivables	$7.600M	$7.500M	$7.300M
Total Short-Term Assets	$297.1M	$299.1M	$271.8M
YoY Change	3.63%	0.67%	23.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$102.0M	$132.5M	$24.87M
YoY Change	300.03%	29.9%	3.94%
Goodwill	$20.98M		$22.79M
YoY Change	-8.18%		-0.14%
Intangibles	$27.77M		$28.10M
YoY Change	-1.41%		2.71%
Long-Term Investments
YoY Change
Other Assets	$7.485M	$122.2M	$6.822M
YoY Change	-12.12%	4.27%	-14.96%
Total Long-Term Assets	$267.9M	$302.6M	$166.9M
YoY Change	55.8%	12.95%	7.44%
TOTAL ASSETS
Total Short-Term Assets	$297.1M	$299.1M	$271.8M
Total Long-Term Assets	$267.9M	$302.6M	$166.9M
Total Assets	$565.0M	$601.7M	$438.7M
YoY Change	23.19%	6.5%	17.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.05M	$25.90M	$28.00M
YoY Change	12.94%	-31.84%	3.59%
Accrued Expenses	$24.54M	$82.60M	$23.03M
YoY Change	49.2%	42.17%	38.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$123.9M	$132.6M	$103.8M
YoY Change	27.81%	7.02%	15.92%
LONG-TERM LIABILITIES
Long-Term Debt	$125.1M	$185.1M	$200.0K
YoY Change	62450.0%	47.96%	100.0%
Other Long-Term Liabilities	$7.773M	$8.300M	$7.680M
YoY Change	2.95%	1.22%	-12.91%
Total Long-Term Liabilities	$7.773M	$193.4M	$7.680M
YoY Change	2.95%	45.09%	-12.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$123.9M	$132.6M	$103.8M
Total Long-Term Liabilities	$7.773M	$193.4M	$7.680M
Total Liabilities	$257.3M	$326.3M	$112.3M
YoY Change	144.53%	25.98%	13.4%
SHAREHOLDERS EQUITY
Retained Earnings	$205.3M		$132.7M
YoY Change	32.11%		78.51%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$185.9M		$83.45M
YoY Change	122.76%		31.09%
Treasury Stock Shares	8.611M shares		4.156M shares
Shareholders Equity	$306.0M	$275.4M	$326.5M
YoY Change
Total Liabilities & Shareholders Equity	$565.0M	$601.7M	$438.7M
YoY Change	23.19%	6.5%	17.08%

Cashflow Statement

Concept	2015 Q1	2015	2013 Q4
OPERATING ACTIVITIES
Net Income	$21.20M	$72.52M	$9.313M
YoY Change	-99.91%	0.02%	-37.94%
Depreciation, Depletion And Amortization	$3.300M	$12.82M	$2.900M
YoY Change	8.45%	0.14%	0.0%
Cash From Operating Activities	$28.80M	$95.61M	$6.100M
YoY Change	18.88%	0.01%	-66.85%
INVESTING ACTIVITIES
Capital Expenditures	-$9.400M	$75.06M	-$3.100M
YoY Change	-408.7%	-195.01%	-18.42%
Acquisitions		$0.00
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	-$9.400M	-$78.96M	-$3.100M
YoY Change	139.12%	-0.05%	-18.42%
FINANCING ACTIVITIES
Cash Dividend Paid		$0.00
YoY Change
Common Stock Issuance & Retirement, Net		$102.5M
YoY Change		-204.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.100M	$26.64M	1.000M
YoY Change	-214.75%	0.16%	-101.77%
NET CHANGE
Cash From Operating Activities	28.80M	$95.61M	6.100M
Cash From Investing Activities	-9.400M	-$78.96M	-3.100M
Cash From Financing Activities	-2.100M	$26.64M	1.000M
Net Change In Cash	17.30M	$43.29M	4.000M
YoY Change	-21.81%	0.21%	-109.52%
FREE CASH FLOW
Cash From Operating Activities	$28.80M	$95.61M	$6.100M
Capital Expenditures	-$9.400M	$75.06M	-$3.100M
Free Cash Flow	$38.20M	$20.55M	$9.200M
YoY Change	80.35%	-88.23%	-58.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	24.83
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M6D
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-03
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-01-03
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000937556
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52613110	shares
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q1	masi	Bank Balances BankBalances	92900000	USD
CY2015	dei	Trading Symbol TradingSymbol	MASI
CY2012Q4	masi	Amount Amortized By Company AmountAmortizedByCompany	200000	USD
CY2013Q4	masi	Amount Amortized By Company AmountAmortizedByCompany	200000	USD
CY2015Q1	masi	Amount Amortized By Company AmountAmortizedByCompany	200000	USD
CY2013Q4	masi	Amount Of Unrecognized Benefits Affecting Future Tax Rate AmountOfUnrecognizedBenefitsAffectingFutureTaxRate	5600000	USD
CY2015Q1	masi	Amount Of Unrecognized Benefits Affecting Future Tax Rate AmountOfUnrecognizedBenefitsAffectingFutureTaxRate	6700000	USD
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	730900000	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	MASIMO CORP
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	masi	Concentration Risk Justintime Distributors ConcentrationRiskJustintimeDistributors	2	distributor
CY2015	masi	Concentration Risk Justintime Distributors ConcentrationRiskJustintimeDistributors	3	distributor
CY2013Q4	masi	Deferred Cost Of Goods Sold DeferredCostOfGoodsSold	61714000	USD
CY2015Q1	masi	Deferred Cost Of Goods Sold DeferredCostOfGoodsSold	67485000	USD
CY2013Q4	masi	Deferred Tax Assets Acquired Intangibles DeferredTaxAssetsAcquiredIntangibles	507000	USD
CY2015Q1	masi	Deferred Tax Assets Acquired Intangibles DeferredTaxAssetsAcquiredIntangibles	437000	USD
CY2007Q4	masi	Dividends Declared For Outstanding Common Stock DividendsDeclaredForOutstandingCommonStock	One preferred stock purchase right
CY2012	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.02
CY2013	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.02
CY2015	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.03
CY2015Q1	masi	Estimateof Annual Preventable Hospital Deaths Preventedby2020 EstimateofAnnualPreventableHospitalDeathsPreventedby2020	200000	death
CY2007Q4	masi	Final Expiration Date Of Right FinalExpirationDateOfRight	2017-11-08
CY2013Q4	masi	Finite Lived Patents Gross Not Amortized FiniteLivedPatentsGrossNotAmortized	6700000	USD
CY2015Q1	masi	Finite Lived Patents Gross Not Amortized FiniteLivedPatentsGrossNotAmortized	6400000	USD
CY2013Q4	masi	Finite Lived Trademarks Gross Not Amortized FiniteLivedTrademarksGrossNotAmortized	700000	USD
CY2015Q1	masi	Finite Lived Trademarks Gross Not Amortized FiniteLivedTrademarksGrossNotAmortized	800000	USD
CY2012	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-1200000	USD
CY2013	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-1200000	USD
CY2015	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-1600000	USD
CY2012	masi	Income Tax Benefit From Exercise Of Stock Options Granted IncomeTaxBenefitFromExerciseOfStockOptionsGranted	338000	USD
CY2013	masi	Income Tax Benefit From Exercise Of Stock Options Granted IncomeTaxBenefitFromExerciseOfStockOptionsGranted	693000	USD
CY2015	masi	Income Tax Benefit From Exercise Of Stock Options Granted IncomeTaxBenefitFromExerciseOfStockOptionsGranted	264000	USD
CY2015	masi	Indefinitely Carryforward Research And Development Credits IndefinitelyCarryforwardResearchAndDevelopmentCredits	3500000	USD
CY2015	masi	Initial Term Of Executive Employment Agreement InitialTermOfExecutiveEmploymentAgreement	P3Y
CY2013Q4	masi	Inventory Finished Goods Held By Distributors InventoryFinishedGoodsHeldByDistributors	3700000	USD
CY2015Q1	masi	Inventory Finished Goods Held By Distributors InventoryFinishedGoodsHeldByDistributors	3600000	USD
CY2013Q4	masi	License Fees Individual LicenseFeesIndividual	500000.0	USD
CY2007Q4	masi	Number Of Rights To Be Issued With Each Share Of Common Stock NumberOfRightsToBeIssuedWithEachShareOfCommonStock	1	shares
CY2007Q1	masi	Numberof Companieswith Rightsto Intellectual Property NumberofCompanieswithRightstoIntellectualProperty	2	company
CY2011Q3	masi	Numberof Former Sales Representatives NumberofFormerSalesRepresentatives	2	sales_representatives
CY2013	masi	Numberof Parameters NumberofParameters	5	parameter
CY2014Q1	masi	Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial	2	participant
CY2012	masi	Royalty Royalty	28305000	USD
CY2015	masi	Numberof Sourcesof Product Revenue NumberofSourcesofProductRevenue	4	segment
CY2015Q1	masi	Operating And Capital Leases Future Minimum Payments Due Current OperatingAndCapitalLeasesFutureMinimumPaymentsDueCurrent	5077000	USD
CY2015Q1	masi	Operating Loss Carryforwards Gross OperatingLossCarryforwardsGross	200000	USD
CY2012	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2013	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2015	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2011	masi	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.03
CY2011	masi	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.03
CY2015Q1	masi	Potential Deferred Tax Expense Undistributed Foreign Earnings PotentialDeferredTaxExpenseUndistributedForeignEarnings	26700000	USD
CY2007Q4	masi	Preferred Stock Voting Rights Per Share PreferredStockVotingRightsPerShare	1.000
CY2015	masi	Product Life Estimate ProductLifeEstimate	P7Y
CY2012	masi	Product Revenue ProductRevenue	464928000	USD
CY2013	masi	Product Revenue ProductRevenue	517429000	USD
CY2015	masi	Product Revenue ProductRevenue	556764000	USD
CY2013	masi	Royalty Royalty	29816000	USD
CY2015	masi	Royalty Royalty	29879000	USD
CY2013Q4	masi	Royalty Receivable RoyaltyReceivable	7300000	USD
CY2015Q1	masi	Royalty Receivable RoyaltyReceivable	7200000	USD
CY2015	masi	Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd	P60D
CY2015Q1	masi	Severance Plan Participation Agreements SeverancePlanParticipationAgreements	7	Agreement
CY2015	masi	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Price Below Market Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermPriceBelowMarketValue	P6Y2M23D
CY2012	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2013	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2015	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2015	masi	Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation	P6M
CY2012	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	-1700000	USD
CY2013	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	300000	USD
CY2015	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	1100000	USD
CY2013Q4	masi	Unamortized Cost By Company UnamortizedCostByCompany	300000	USD
CY2015Q1	masi	Unamortized Cost By Company UnamortizedCostByCompany	600000	USD
CY2013Q4	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	5769000	USD
CY2015Q1	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	6812000	USD
CY2013Q4	masi	Variable Interest Entities Other Assets Long Term VariableInterestEntitiesOtherAssetsLongTerm	6822000	USD
CY2015Q1	masi	Variable Interest Entities Other Assets Long Term VariableInterestEntitiesOtherAssetsLongTerm	7485000	USD
CY2013Q4	masi	Variable Interest Entities Prepaid Expenses VariableInterestEntitiesPrepaidExpenses	3740000	USD
CY2015Q1	masi	Variable Interest Entities Prepaid Expenses VariableInterestEntitiesPrepaidExpenses	417000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28004000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	38045000	USD
CY2013Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	76759000	USD
CY2015Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	71017000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2406000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6562000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23028000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24541000	USD
CY2013Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	700000	USD
CY2015Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	400000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49415000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57084000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	3995000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2093000	USD
CY2012	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	273129000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288686000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14097000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11674000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11005000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	-410000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	-615000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	-132000	USD
CY2012	us-gaap	Advertising Expense AdvertisingExpense	9600000	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	9600000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	10700000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14097000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11674000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11005000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1833000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1890000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6400000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares
CY2013Q4	us-gaap	Assets Assets	438662000	USD
CY2015Q1	us-gaap	Assets Assets	565006000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	271798000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	315141000	USD
CY2012Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	14600000	USD
CY2012	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	776000	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	507000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12155000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	111000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	79000	USD
CY2012	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	21000	USD
CY2013	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	352000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	225000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	145000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	242000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	87000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134453000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-58328000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	75000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	80000	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	100000	USD
CY2013Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	0	USD
CY2015Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	500000	USD
CY2013Q4	us-gaap	Cash Cash	67700000	USD
CY2015Q1	us-gaap	Cash Cash	92900000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129882000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71554000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95466000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23912000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	38987000	USD
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	27800000	USD
CY2015Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	41600000	USD
CY2015Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	2600000	USD
CY2015Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	40500000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	15700000	shares
CY2012Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2012	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1
CY2013	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56623000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52594000	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	57000	USD
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	64540000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	58834000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66430000	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3395000	USD
CY2015Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	25731000	USD
CY2015Q1	us-gaap	Contractual Obligation ContractualObligation	16649000	USD
CY2015Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1033000	USD
CY2015Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	1870000	USD
CY2015Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1930000	USD
CY2015Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	4168000	USD
CY2015Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	2571000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	166982000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	188418000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	195864000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	26332000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	24488000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	22553000	USD
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-54000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1704000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2709000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28689000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28618000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27998000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2411000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2426000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2736000	USD
CY2013Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	20000	USD
CY2015Q1	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	5000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5546000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7281000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	342000	USD
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	198000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-362000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	149000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6806000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8613000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-320000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	533000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	230000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20755000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	21067000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	566000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	453000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1458000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-970000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-811000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4234000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4943000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	47461000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	47711000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	42201000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	42258000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	19636000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	18065000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	22565000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	11005000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	24193000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	43898000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	44346000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	19636000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	18065000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	22565000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	24193000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	277000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	670000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	584000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	19385000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	21594000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	2149000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	2162000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	17036000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	14723000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3563000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3365000	USD
CY2012	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	400000	USD
CY2013	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	700000	USD
CY2015	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	200000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1697000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2088000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1697000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2088000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	86000000	USD
CY2012	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1400000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1500000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1700000	USD
CY2015	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2012	us-gaap	Depreciation Depreciation	7300000	USD
CY2013	us-gaap	Depreciation Depreciation	8300000	USD
CY2015	us-gaap	Depreciation Depreciation	9100000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9369000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11421000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12818000	USD
CY2012Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-12-11
CY2012Q4	us-gaap	Dividends Cash DividendsCash	57300000	USD
CY2012	us-gaap	Dividends Cash DividendsCash	57275000	USD
CY2012Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-11-27
CY2013Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	290000	USD
CY2015Q1	us-gaap	Due From Employees Current DueFromEmployeesCurrent	385000	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	14300000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	218000	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	552000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4304000	USD
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.261
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.264
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.271
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.030
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	-0.005
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	-0.006
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.101
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.098
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.082
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.010
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.009
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.013
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.005
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.035
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.015
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29486000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33600000	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	21100000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y4M10D
CY2012	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4900000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3900000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3700000	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-748000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-1308000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-396000	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-748000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-1308000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-396000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9814000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13015000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	13010000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3359000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2455000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2690000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3042000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3215000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	37918000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40786000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28104000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27771000	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1600000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1000000	USD
CY2012	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	586000	USD
CY2013	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	USD
CY2015	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-249000	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-368000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	22824000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	22793000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	20979000	USD
CY2012	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2013	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2015	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2013	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-31000	USD
CY2015	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-1814000	USD
CY2012	us-gaap	Gross Profit GrossProfit	326251000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	89581000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	91232000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	87479000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	90536000	USD
CY2013	us-gaap	Gross Profit GrossProfit	358827000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	92301000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	93095000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	96224000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
	us-gaap	Gross Profit GrossProfit	109159000	USD
CY2015	us-gaap	Gross Profit GrossProfit	390779000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	59216000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	50782000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	69282000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	24605000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	24944000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	32759000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	83821000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	75726000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	102041000	USD
CY2013	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	1000000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21883000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20005000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27678000	USD
CY2015	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	500000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	28691000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	29979000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	19863000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2037000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1238000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1375000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10130000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9576000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4862000	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	198000	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-381000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3909000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2939000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6406000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1837000	USD
CY2012	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	409000	USD
CY2013	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	9594000	USD
CY2015	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	5888000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2850000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1467000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	199000	USD
CY2012	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4827000	USD
CY2013	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4557000	USD
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4948000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-539000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9453000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13434000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2035000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	756000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2619000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2203000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-842000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	227000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1255000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	1660000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-3316000	USD
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	929000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	790000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	863000	shares
CY2012	us-gaap	Interest Paid Net InterestPaidNet	44000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	28000	USD
CY2015	us-gaap	Interest Paid Net InterestPaidNet	469000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23745000	USD
CY2015Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	30642000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	56813000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	69718000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28104000	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27771000	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	USD
CY2015	us-gaap	Interest Expense Debt InterestExpenseDebt	600000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26758000	USD
CY2015Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	33056000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6310000	USD
CY2015Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6020000	USD
CY2015	us-gaap	Investment Tax Credit InvestmentTaxCredit	500000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4600000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5100000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6100000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	112261000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	257265000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	438662000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	565006000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	103790000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	123894000	USD
CY2013Q4	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2015Q1	us-gaap	Line Of Credit LineOfCredit	125000000	USD
CY2014Q4	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	466800000	USD
CY2012	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2013	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	8010000	USD
CY2015	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-10331000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	225000	USD
CY2015Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	125145000	USD
CY2014Q1	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	-8000000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-68000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	1742000	USD
CY2015	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	38000	USD
CY2013Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	1800000	USD
CY2015Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	1100000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-82089000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17941000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26246000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-51580000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13286000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-78414000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	75123000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54587000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	95459000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	62272000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	16428000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	17038000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	15602000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	9313000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	58381000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	22632000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	13802000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	14863000	USD
	us-gaap	Net Income Loss NetIncomeLoss	21221000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	72518000	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-334000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2660000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1845000	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1405000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3991000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1472000	USD
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2013Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1358000	USD
CY2015Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	726000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	241025000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	279110000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	287266000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	85226000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	23141000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	23180000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	20743000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	12653000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	79717000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	30193000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	18405000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	22268000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	32647000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	103513000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	16407000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4990000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1870000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.317
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.025
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1930000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2496000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4088000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1033000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	19384000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	21471000	USD
CY2013Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	2551000	USD
CY2015Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4070000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6822000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7485000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	2100000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-6088000	USD
CY2015	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	0	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26268000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19790000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	102453000	USD
CY2012	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7680000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7773000	USD
CY2012	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	-586000	USD
CY2013	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	0	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2268000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	453000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6088000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-168000	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	436000	USD
CY2012	us-gaap	Payments Of Dividends PaymentsOfDividends	57275000	USD
CY2013	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2015	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	37399000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3664000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3926000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3353000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10517000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9360000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75061000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9243000	USD
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9816000	USD
CY2013Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3740000	USD
CY2015Q1	us-gaap	Prepaid Taxes PrepaidTaxes	417000	USD
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	125000000	USD
CY2012	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2013	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.366
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.312
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3289000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2015	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-38000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1642000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	838000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1161000	USD
CY2015	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1144000	USD
CY2012	us-gaap	Product Warranty Expense ProductWarrantyExpense	-128000	USD
CY2013	us-gaap	Product Warranty Expense ProductWarrantyExpense	-52000	USD
CY2015	us-gaap	Product Warranty Expense ProductWarrantyExpense	-138000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.432
CY2012	us-gaap	Profit Loss ProfitLoss	61938000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4680000	USD
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	623000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1416000	USD
CY2012	us-gaap	Product Warranty Accrual Additions From Business Acquisition ProductWarrantyAccrualAdditionsFromBusinessAcquisition	170000	USD
CY2012	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	722000	USD
CY2013	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1289000	USD
CY2015	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1027000	USD
CY2012	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	639000	USD
CY2013	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1560000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	55721000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	74363000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	74281000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	159036000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24866000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101952000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	231000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	728000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	583000	USD
CY2015Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	67100000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	76759000	USD
CY2015Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	71017000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	26000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	132000	USD
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	111000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47077000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55631000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56581000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	132742000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	205260000	USD
CY2012	us-gaap	Revenues Revenues	493233000	USD
CY2013Q1	us-gaap	Revenues Revenues	135942000	USD
CY2013Q2	us-gaap	Revenues Revenues	137422000	USD
CY2013Q3	us-gaap	Revenues Revenues	131447000	USD
CY2013Q4	us-gaap	Revenues Revenues	142435000	USD
CY2013	us-gaap	Revenues Revenues	547245000	USD
CY2014Q1	us-gaap	Revenues Revenues	139814000	USD
CY2014Q2	us-gaap	Revenues Revenues	140923000	USD
CY2014Q3	us-gaap	Revenues Revenues	144118000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.426
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.396
	us-gaap	Revenues Revenues	161788000	USD
CY2015	us-gaap	Revenues Revenues	586643000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	193948000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	215469000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	241016000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	14097000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	11674000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.365
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.367
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.013
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	11200000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5759000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4632000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5188000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.009
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.007
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.007
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4934000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5795000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5859000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.29
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.69
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.63
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3100000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4200000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6600000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	447000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	795000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	416000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	754000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1653000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1887000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.98
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.53
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.85
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	37500000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8277000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8368000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8911000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9956000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.68
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.78
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.76
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.59
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	24600000	USD
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.62
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.49
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.95
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2015Q1	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	305999000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	279666000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	275668000	USD
CY2011Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3000000.0	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	326469000	USD
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	27.30
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.53
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.46
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.17
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3290000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4683000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M13D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y11M9D
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.17
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	216000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	315000	shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	426000	shares
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	12300000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1642000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	326401000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307741000	USD
CY2013Q4	us-gaap	Tax Credit Carryforward Deferred Tax Asset TaxCreditCarryforwardDeferredTaxAsset	3203000	USD
CY2015Q1	us-gaap	Tax Credit Carryforward Deferred Tax Asset TaxCreditCarryforwardDeferredTaxAsset	3260000	USD
CY2015Q1	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	40500000	USD
CY2012	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	22.74
CY2013	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	19.79
CY2015	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	23.00
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	4156000	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	8611000	shares
CY2012	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1155000	shares
CY2013	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1000000	shares
CY2015	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4455000	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	83454000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	185906000	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	26268000	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	19791000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	102453000	USD
CY2013Q4	us-gaap	Us Government Agencies Securities At Carrying Value USGovernmentAgenciesSecuritiesAtCarryingValue	26000000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6685000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6630000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8024000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	443000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	900000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	900000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	695000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	958000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	265000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	830000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	572000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	394000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58374000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57480000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55571000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57445000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56690000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54708000	shares
CY2015	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week fiscal year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The Company’s year ended January 3, 2015 was a 53 week fiscal year while the years ended December 28, 2013 and December 29, 2012 were each 52 week fiscal years. All references to years in these notes to consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company), is a global medical technology company that develops, manufactures and markets a variety of noninvasive monitoring technologies. The Company’s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The Company’s patient monitoring solutions generally incorporate a monitor or circuit board and sensors, proprietary single-patient use, reusable and resposable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service (EMS) providers, physician offices, veterinarians, long term care facilities and consumers, directly through distributors and through original equipment manufacturer (OEM) partners. The Company considers its pulse oximetry devices (monitor or circuit board), sensors, cables and software to be products as defined in its consolidated statements of comprehensive income. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s core business is Measure-Through-Motion and Low-Perfusion pulse oximetry, known as Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> (Masimo SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), which addresses the primary limitations of conventional pulse oximetry. Over the years, the Company’s product offerings have expanded significantly to also include noninvasive blood constituent, brain and breath monitoring, such as rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> Pulse CO-Oximetry, brain function electroencephalogram (EEG) monitoring, respiration rate, capnography and anesthetic agent monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> remote patient surveillance monitoring system. These solutions and related products are based upon proprietary Masimo SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers’ specifications. This technology is supported by a substantial intellectual property portfolio that the Company has built through internal development and, to a lesser extent, acquisitions and license agreements.</font></div></div>
CY2015	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the consolidated financial statements for prior periods have been reclassified to conform to current period presentation. </font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company’s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and related accruals. Actual results could differ from such estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000937556-15-000024-index-headers.html	Edgar Link	pending
0000937556-15-000024-index.html	Edgar Link	pending
0000937556-15-000024.txt	Edgar Link	pending
0000937556-15-000024-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
masi-20150103.xml	Edgar Link	completed
masi-20150103.xsd	Edgar Link	pending
masi-20150103x10k.htm	Edgar Link	pending
masi-20150103x10kex1011.htm	Edgar Link	pending
masi-20150103x10kex1012.htm	Edgar Link	pending
masi-20150103x10kex1021.htm	Edgar Link	pending
masi-20150103x10kex1030.htm	Edgar Link	pending
masi-20150103x10kex1032.htm	Edgar Link	pending
masi-20150103x10kex1034.htm	Edgar Link	pending
masi-20150103x10kex1044.htm	Edgar Link	pending
masi-20150103x10kex121.htm	Edgar Link	pending
masi-20150103x10kex211.htm	Edgar Link	pending
masi-20150103x10kex311.htm	Edgar Link	pending
masi-20150103x10kex312.htm	Edgar Link	pending
masi-20150103x10kex321.htm	Edgar Link	pending
masi-20150103_cal.xml	Edgar Link	unprocessable
masi-20150103_def.xml	Edgar Link	unprocessable
masi-20150103_lab.xml	Edgar Link	unprocessable
masi-20150103_pre.xml	Edgar Link	unprocessable
masi-2015x0103x10kex231.htm	Edgar Link	pending
masi20131228chart.jpg	Edgar Link	pending
masimoletterheadlogo.jpg	Edgar Link	pending
masimologo300a08.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MASI
MASIMO CORP Stock $masi

2015 Q1 Form 10-K Financial Statement

#000093755615000024 Filed on February 17, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI MASIMO CORP Stock $masi

2015 Q1 Form 10-K Financial Statement

#000093755615000024 Filed on February 17, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI
MASIMO CORP Stock $masi